Cargando…

Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 Diabetes

Trials have demonstrated the preventability of type 2 diabetes through lifestyle modifications or drugs in people with impaired glucose tolerance. However, alternative ways of identifying people at risk of developing diabetes are required. Multivariate risk scores have been developed for this purpos...

Descripción completa

Detalles Bibliográficos
Autores principales: Buijsse, Brian, Simmons, Rebecca K., Griffin, Simon J., Schulze, Matthias B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132807/
https://www.ncbi.nlm.nih.gov/pubmed/21622851
http://dx.doi.org/10.1093/epirev/mxq019
_version_ 1782207875775463424
author Buijsse, Brian
Simmons, Rebecca K.
Griffin, Simon J.
Schulze, Matthias B.
author_facet Buijsse, Brian
Simmons, Rebecca K.
Griffin, Simon J.
Schulze, Matthias B.
author_sort Buijsse, Brian
collection PubMed
description Trials have demonstrated the preventability of type 2 diabetes through lifestyle modifications or drugs in people with impaired glucose tolerance. However, alternative ways of identifying people at risk of developing diabetes are required. Multivariate risk scores have been developed for this purpose. This article examines the evidence for performance of diabetes risk scores in adults by 1) systematically reviewing the literature on available scores and 2) their validation in external populations; and 3) exploring methodological issues surrounding the development, validation, and comparison of risk scores. Risk scores show overall good discriminatory ability in populations for whom they were developed. However, discriminatory performance is more heterogeneous and generally weaker in external populations, which suggests that risk scores may need to be validated within the population in which they are intended to be used. Whether risk scores enable accurate estimation of absolute risk remains unknown; thus, care is needed when using scores to communicate absolute diabetes risk to individuals. Several risk scores predict diabetes risk based on routine noninvasive measures or on data from questionnaires. Biochemical measures, in particular fasting plasma glucose, can improve prediction of such models. On the other hand, usefulness of genetic profiling currently appears limited.
format Online
Article
Text
id pubmed-3132807
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-31328072011-07-12 Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 Diabetes Buijsse, Brian Simmons, Rebecca K. Griffin, Simon J. Schulze, Matthias B. Epidemiol Rev Articles Trials have demonstrated the preventability of type 2 diabetes through lifestyle modifications or drugs in people with impaired glucose tolerance. However, alternative ways of identifying people at risk of developing diabetes are required. Multivariate risk scores have been developed for this purpose. This article examines the evidence for performance of diabetes risk scores in adults by 1) systematically reviewing the literature on available scores and 2) their validation in external populations; and 3) exploring methodological issues surrounding the development, validation, and comparison of risk scores. Risk scores show overall good discriminatory ability in populations for whom they were developed. However, discriminatory performance is more heterogeneous and generally weaker in external populations, which suggests that risk scores may need to be validated within the population in which they are intended to be used. Whether risk scores enable accurate estimation of absolute risk remains unknown; thus, care is needed when using scores to communicate absolute diabetes risk to individuals. Several risk scores predict diabetes risk based on routine noninvasive measures or on data from questionnaires. Biochemical measures, in particular fasting plasma glucose, can improve prediction of such models. On the other hand, usefulness of genetic profiling currently appears limited. Oxford University Press 2011-07 2011-05-27 /pmc/articles/PMC3132807/ /pubmed/21622851 http://dx.doi.org/10.1093/epirev/mxq019 Text en Epidemiologic Reviews © The Author 2011. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Buijsse, Brian
Simmons, Rebecca K.
Griffin, Simon J.
Schulze, Matthias B.
Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 Diabetes
title Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 Diabetes
title_full Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 Diabetes
title_fullStr Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 Diabetes
title_full_unstemmed Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 Diabetes
title_short Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 Diabetes
title_sort risk assessment tools for identifying individuals at risk of developing type 2 diabetes
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132807/
https://www.ncbi.nlm.nih.gov/pubmed/21622851
http://dx.doi.org/10.1093/epirev/mxq019
work_keys_str_mv AT buijssebrian riskassessmenttoolsforidentifyingindividualsatriskofdevelopingtype2diabetes
AT simmonsrebeccak riskassessmenttoolsforidentifyingindividualsatriskofdevelopingtype2diabetes
AT griffinsimonj riskassessmenttoolsforidentifyingindividualsatriskofdevelopingtype2diabetes
AT schulzematthiasb riskassessmenttoolsforidentifyingindividualsatriskofdevelopingtype2diabetes